William H. Farland

5.8k total citations · 1 hit paper
46 papers, 4.5k citations indexed

About

William H. Farland is a scholar working on Health, Toxicology and Mutagenesis, Cancer Research and Sociology and Political Science. According to data from OpenAlex, William H. Farland has authored 46 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Health, Toxicology and Mutagenesis, 16 papers in Cancer Research and 8 papers in Sociology and Political Science. Recurrent topics in William H. Farland's work include Effects and risks of endocrine disrupting chemicals (15 papers), Carcinogens and Genotoxicity Assessment (15 papers) and Toxic Organic Pollutants Impact (10 papers). William H. Farland is often cited by papers focused on Effects and risks of endocrine disrupting chemicals (15 papers), Carcinogens and Genotoxicity Assessment (15 papers) and Toxic Organic Pollutants Impact (10 papers). William H. Farland collaborates with scholars based in United States, Switzerland and Canada. William H. Farland's co-authors include Linda S. Birnbaum, Dieter Schrenk, Mark Feeley, Nigel J. Walker, Laurie C. Haws, Helen Håkansson, Chiharu Tohyama, Annika Hanberg, Angelika Tritscher and Richard E. Peterson and has published in prestigious journals such as Science, Nature Biotechnology and Analytical Biochemistry.

In The Last Decade

William H. Farland

44 papers receiving 4.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The 2005 World Health Organization Reevaluation of Human and Mammalian Toxic Equivalency Factors for Dioxins and Dioxin-Like Compounds

2006 3.0k citations Martin van den Berg, Linda S. Birnbaum et al. Toxicological Sciences profile →

Peers

Countries citing papers authored by William H. Farland

Since Specialization

Citations

This map shows the geographic impact of William H. Farland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William H. Farland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William H. Farland more than expected).

Fields of papers citing papers by William H. Farland

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William H. Farland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William H. Farland. The network helps show where William H. Farland may publish in the future.

Co-authorship network of co-authors of William H. Farland

This figure shows the co-authorship network connecting the top 25 collaborators of William H. Farland. A scholar is included among the top collaborators of William H. Farland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William H. Farland. William H. Farland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Improving risk assessment approaches for chemicals with both endogenous and exogenous exposures 2019 ·Regulatory Toxicology and Pharmacology ·William H. Farland, (unknown), (unknown), Lynn H. Pottenger	7
2	Approaches for describing and communicating overall uncertainty in toxicity characterizations: U.S. Environmental Protection Agency's Integrated Risk Information System (IRIS) as a case study 2016 ·Environment International ·Nancy B. Beck, Richard A. Becker, (unknown), William H. Farland, Roberta L. Grant, George M. Gray, Christopher R. Kirman, Judy S. LaKind, R. Jeffrey Lewis, (unknown), Lynn H. Pottenger, Susan L. Santos, (unknown), Ted W. Simon, Michael L. Dourson	30
3	Identification and Characterization of Adverse Effects in 21st Century Toxicology 2012 ·Toxicological Sciences ·Douglas A. Keller, Daland R. Juberg, (unknown), William H. Farland, Frederick G. Hess, Douglas C. Wolf, Nancy G. Doerrer	60
4	Re Human and Mammalian Toxic Equivalency Factors for Dioxins and Dioxin-Like Compounds: The Who 2005 Re-Evaluation 2006 ·Organohalogen compounds ·Martin van den Berg, Linda S. Birnbaum, (unknown), (unknown), William H. Farland, Mark Feeley, Heidelore Fiedler, Helen Håkansson, Annika Hanberg, Laurie C. Haws, Martin Rose, Stephen Safe, Dieter Schrenk, Chiharu Tohyama, Angelika Tritscher, Jouko Tuomisto, Mats Tysklind, Neil Walker, (unknown)	5
5	The 2005 World Health Organization Reevaluation of Human and Mammalian Toxic Equivalency Factors for Dioxins and Dioxin-Like Compounds breakdown → 2006 ·Toxicological Sciences ·Martin van den Berg, Linda S. Birnbaum, Michael S. Denison, (unknown), William H. Farland, Mark Feeley, Heidelore Fiedler, Helen Håkansson, Annika Hanberg, Laurie C. Haws, Martin Rose, Stephen Safe, Dieter Schrenk, Chiharu Tohyama, Angelika Tritscher, Jouko Tuomisto, Mats Tysklind, Nigel J. Walker, Richard E. Peterson	2956
6	IPCS Framework for Analyzing the Relevance of a Cancer Mode of Action for Humans 2006 ·Critical Reviews in Toxicology ·Alan R. Boobis, Samuel M. Cohen, Vicki L. Dellarco, Douglas McGregor, M.E. Meek, Carolyn Vickers, (unknown), William H. Farland	345
7	Development of a Refined Database of Mammalian Relative Potency Estimates for Dioxin-like Compounds 2005 ·Toxicological Sciences ·Laurie C. Haws, Steave H. Su, Mark Anglin Harris, Michael J. DeVito, Nigel J. Walker, William H. Farland, Brent L. Finley, Linda S. Birnbaum	104
8	EPA Risk Assessment Principles and Practices. BOSC (Board of Scientific Counselors) Workshop. February 2–3, 2005, Washington, DC 2005 ·Environmental Science and Pollution Research ·Rogene Henderson, (unknown), George P. Daston, Clifford S. Duke, William H. Farland	1
9	Research Strategies for Safety Evaluation of Nanomaterials, Part II: Toxicological and Safety Evaluation of Nanomaterials, Current Challenges and Data Needs 2005 ·Toxicological Sciences ·Michael P. Holsapple, William H. Farland, Timothy D. Landry, Nancy A. Monteiro‐Riviere, Janet M. Carter, Nigel J. Walker, Karluss Thomas	178
10	Rodent Toxicity and Nongenotoxic Carcinogenesis: Knowledge-Based Human Risk Assessment Based on Molecular Mechanisms 2003 ·Toxicology Mechanisms and Methods ·Ruth Roberts, Jay I. Goodman, Howard G. Shertzer, T. P. Dalton, William H. Farland	3
11	Contrasting Roles of Epidemiology in Dioxin-related Policy: Lessons Learned 2001 ·American Journal of Epidemiology ·Joseph V. Rodricks, James J. Collins, William H. Farland, David J. Tollerud	2
12	Current risk assessment approaches in different countries 2000 ·Food Additives & Contaminants ·(unknown), William H. Farland, Dwain Winters	19
13	Dioxins: WHO’s tolerable daily intake (TDI) revisited 2000 ·Chemosphere ·F.X.R. van Leeuwen, Mark Feeley, Dieter Schrenk, John Christian Larsen, William H. Farland, Maged Younes	273
14	New directions in cancer risk assessment: Accuracy, precision, credibility, and uncertainty 1997 ·Human and Ecological Risk Assessment An International Journal ·William H. Farland, (unknown)	2
15	Cancer Risk Assessment: Evolution of the Process 1996 ·Preventive Medicine ·William H. Farland	9
16	Status of Dioxin-related activities at the United States Environmental Protection Agency (U.S. EPA) 1994 ·Organohalogen compounds ·William H. Farland	6
17	Dissent (A) Environmental tobacco smoke: A public health conspiracy? A dissenting view 1994 ·Journal of Clinical Epidemiology ·William H. Farland, Steven Bayard, Jennifer Jinot	5
18	Incorporating cell proliferation in quantitative cancer risk assessment: approaches, issues, and uncertainties. 1991 ·PubMed ·(unknown), William H. Farland	12
19	The Significance of DNA Damage and Repair Mechanisms in Health Risk Assessment 1990 ·PubMed ·Lorenz R. Rhomberg, Vicki L. Dellarco, William H. Farland, (unknown)	2
20	Introduction to the U.S. environmental protection agency's genetic risk assessment on ethylene oxide 1990 ·Environmental and Molecular Mutagenesis ·Vicki L. Dellarco, William H. Farland, John P. O’Neill	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact